Why the study?
Does a routine strategy of rhythm control reduce death from cardiovascular causes in patients with atrial fibrillation and congestive heart failure?
Does a routine strategy of rhythm control reduce death from cardiovascular causes in patients with atrial fibrillation and congestive heart failure?
A routine rhythm-control strategy does not reduce cardiovascular mortality compared to rate control in patients with concurrent atrial fibrillation and congestive heart failure.
Establishes rate control as a safe primary strategy in concurrent AF and HF; challenges the historical.
In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.)
No takes yet. Share an insight, caveat, or question.
Roy et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: